Alamar Capital Management LLC Decreases Stock Position in HCA Healthcare, Inc. $HCA

Alamar Capital Management LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 24.7% in the second quarter, Holdings Channel reports. The fund owned 9,800 shares of the company’s stock after selling 3,206 shares during the quarter. HCA Healthcare makes up about 2.0% of Alamar Capital Management LLC’s holdings, making the stock its 22nd biggest holding. Alamar Capital Management LLC’s holdings in HCA Healthcare were worth $3,754,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in HCA. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $27,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Bank of America raised their price objective on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 10th. Royal Bank Of Canada reduced their price objective on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research note on Monday, July 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $437.19.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $440.07 on Friday. The firm has a market capitalization of $102.97 billion, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 1.39 and a beta of 1.40. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $447.09. The stock’s fifty day moving average is $413.82 and its 200-day moving average is $380.88.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $5.50 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.